petasites hybridus leaf extract
Botanicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
1
Earliest trial started Jan 1, 2008 (NCT00862225)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cosalin
- petasites hybridus leaf extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01062139 | Phase 4 | Oct 1, 2009 | CJ HealthCare Corp. |
| NCT00862225 | Phase 2 | Jan 1, 2008 | Max Zeller Soehne AG |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CJ HealthCare Corp. | For profit | 1 | 1 | 1 | 2009 |
| Max Zeller Soehne AG | For profit | 1 | 1 | 1 | 2008 |
2 organizations
Page 1 / 1